As a result of Monday's trading, the European stock indices increased. This was aided by the continued decline in oil prices, which eased fears of rising inflation and increased risk appetite in the markets. Stoxx Europe 600 summary index of the region's largest companies rose by 1.02%, reaching 641.93 points. Britain's FTSE 100 rose by 0.75%, Germany's DAX by 1.07%, France's CAC 40 by 0.92%, Italy's FTSE MIB by 1.6% and Spain's IBEX 35 by 1.08%. On Monday, the price of Brent oil dropped below 100 dollars (per barrel) for the first time since September 9. This is due to the hopes of resuming diplomatic efforts to settle the conflict between the United States and Iran. In France, the state of the state budget continues to be in the center of attention. In an interview with the Parisien magazine, the president of the country's Audit Chamber, Amelie de Montchalin, stated that the cost of servicing the public debt will increase by 2030, reaching 100 billion euros per year. One of the key events for the markets this week will be the meeting between Trump and Chinese President Xi Jinping. Before that, the representatives of the two countries announced successful consultations on the issues of trade and the development of artificial intelligence. On Monday, the leader of growth in the Stoxx Europe 600 list was the Polish mBank (+8.3%). Other representatives of the banking sector also recorded positive dynamics, including: Erste Bank Polska (+5.5%), Banco BPM (+4.3%), UniCredit (+3.2%), Commerzbank (+3%), FinecoBank (+2.3%), Bankinter (+2.2%), Banco de Sabadell (+2.1%), Barclays (+1.9%) and Societe Generale (+1.8%). The market value of technological companies has increased significantly. Soitec gained 9.8%, Aixtron - 5.1%, Infineon Technologies - 4.5%, ASML Holding - 2.5% and STMicroelectronics - 2.1%. Shares of Swiss logistics giant Kuehne+Nagel rose 5.4% after the company announced a long-term strategic partnership with Amazon.com. Novo Nordisk's shares registered the biggest fall in the summary index (-7.7%). The Danish pharmaceutical giant has announced that it expects to increase the revenue from the sale of drugs under development to 150 billion Danish kroner ($23 billion) by 2035, and plans to increase the revenue from the market by 2026-2030. at low annual rates. This forecast disappointed investors who were expecting a clearer presentation of steps aimed at strengthening the company's position. The drop in oil prices has negatively affected the quotations of oil refining companies. Equinor fell by 3.4%, BP Plc by 2.8%, Shell by 1.4%, Repsol by 1.3%, TotalEnergies by 1% and Eni by 0.9%.